Brefeldin A and Cytochalasin B Reduce Dengue Virus Replication in Cell Cultures but Do Not Protect Mice Against Viral Challenge
Overview
Authors
Affiliations
Background: Dengue is an emerging arboviral disease caused by dengue virus (DENV). DENV belongs to the family and genus . No specific anti-DENV drugs are currently available.
Methods: We investigated the antiviral activity of Brefeldin A (BFA) and Cytochalasin B (CB) against this infection. The drugs BFA and CB were used in the treatment of dengue-2 virus (DENV-2) infections in Vero cell cultures and in protection from lethality by post-challenge administration in Swiss mice. Viral load was quantified by qRT-PCR and plaque assay in Vero cell cultures, post-infection, treated or not with the drugs. Post-challenge drug levels were evaluated by survival analysis.
Results: Our results indicate that doses of 5 µg ml of BFA and 10 µg ml of CB are not toxic to the cells and induce a statistically significant inhibition of DENV-2 replication in Vero cells when compared to control. No BFA- or CB-treated mice survived the challenge with DENV-2.
Conclusion: These data suggest that BFA and CB have an antiviral action against DENV-2 replication in Vero cell culture, but do not alter infected mice mortality.
Impact of Tick-Borne Infection on Compact Human Brain Endothelial Barrier.
Schweitzer F, Letoha T, Osterhaus A, Prajeeth C Int J Mol Sci. 2025; 26(5).
PMID: 40076965 PMC: 11901142. DOI: 10.3390/ijms26052342.
Bolivar-Marin S, Bosch I, Narvaez C J Trop Med. 2022; 2022:2177183.
PMID: 35911823 PMC: 9325612. DOI: 10.1155/2022/2177183.
Prattay K, Sarkar M, Shafiullah A, Islam M, Raihan S, Sharmin N PLoS Negl Trop Dis. 2022; 16(4):e0010297.
PMID: 35377886 PMC: 8979461. DOI: 10.1371/journal.pntd.0010297.
Sebola T, Uche-Okereafor N, Mekuto L, Makatini M, Green E, Mavumengwana V Int J Microbiol. 2021; 2020:8839490.
PMID: 33488726 PMC: 7803143. DOI: 10.1155/2020/8839490.
Hajjo R, Tropsha A Pharm Res. 2020; 37(11):212.
PMID: 33025261 PMC: 7537965. DOI: 10.1007/s11095-020-02930-9.